Back

dr. M. (Mischa) de Ridder

dr. M. (Mischa) de Ridder

Assistant Professor - medical

Show full profile

Research Output (26)

Metrics of pN-staging in oral squamous cell carcinoma:An analysis of 1,905 patients

Mirian Christian, Gerds Thomas A., Pedersen Maria M., de Ridder Mischa, Balm Alfons, Mattavelli Davide, Piazza Cesare, Jensen Lasse R., Balasubramanian Deepak, Subramaniam Narayana, Dokhe Yogesh, Thankappan Krishnakumar, Iyer Subramania, Karam Sana D., Wiegand Susanne, Feeley Linda, Milross Chris, Gao Kan, Palme Carsten E., Low Tsu Hui (Hubert), Gupta Ruta, Freudlsperger Christian, Moratin Julius, Sheahan Patrick, Clark Jonathan, Ovesen Therese Jun 2021, In: European Journal of Cancer. 150 , p. 33-41 9 p.

Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands

Valstar Matthijs H., Schaapveld Michael, van den Broek Esther C., van Velthuysen Marie Louise F., de Ridder Mischa, Schmidt Marjanka K., van Dijk Boukje A.C., Balm Alfons J.M., Smeele Ludi E. Jan 2021, In: Cancer Medicine. 10 , p. 424-434 11 p.

Anaplastic thyroid carcinoma:a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades

de Ridder Mischa, van Dijkum Els Nieveen, Engelsman Anton, Kapiteijn Ellen, Klümpen Heinz Josef, Rasch Coen R.N. Aug 2020, In: European Journal of Endocrinology. 183 , p. 203-209 7 p.

BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer:A safety and performance trial

De Ridder Mischa, Gerbrandy Lara C., de Reijke Theo M., Hinnen Karel A., Hulshof Maarten C.C.M. 1 Jul 2020, In: British Journal of Radiology. 93 , p. 20200241

Disease course after the first recurrence of head and neck squamous cell carcinoma following (chemo)radiation

de Ridder Mischa, de Veij Mestdagh Pieter D., Elbers Joris B.W., Navran Arash, Zuur Charlotte L., Smeele Ludi E., Al-Mamgani Abrahim 1 Jan 2020, In: European Archives of Oto-Rhino-Laryngology. 277 , p. 261-268 8 p.

FDG-PET/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation

de Ridder Mischa, Gouw Zeno A.R., Navran Arash, Hamming-Vrieze Olga, Jasperse Bas, van den Brekel Michiel W.M., Vogel Wouter V., Al-Mamgani A. 1 May 2019, In: European Archives of Oto-Rhino-Laryngology. 276 , p. 1447-1455 9 p.

The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma

Al-Mamgani A., de Ridder M., Navran A., Klop W. M., de Boer J. P., Tesselaar M. E. 1 Oct 2017, In: European Archives of Oto-Rhino-Laryngology. 274 , p. 3757-3765 9 p.

Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy

de Ridder Mischa, Klop Martin, Hamming-Vrieze Olga, de Boer Jan Paul, Jasperse Bas, Smit Laura, Vogel Wouter, van den Brekel Michiel, Al-Mamgani Abrahim Jul 2017, In: Head and Neck. 39 , p. 1382-1391 10 p.

Salivary gland pleomorphic adenoma in the Netherlands:A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence

Valstar M. H., de Ridder M., van den Broek E. C., Stuiver M. M., van Dijk B. A.C., van Velthuysen M. L.F., Balm A. J.M., Smeele L. E. 1 Mar 2017, In: Oral Oncology. 66 , p. 93-99 7 p.

Recurrent oropharyngeal cancer after organ preserving treatment:pattern of failure and survival

de Ridder M., Gouw Z. A.R., Sonke J. J., Navran A., Jasperse B., Heukelom J., Tesselaar M. E.T., Klop W. M.C., van den Brekel M. W.M., Al-Mamgani Abrahim 1 Mar 2017, In: European Archives of Oto-Rhino-Laryngology. 274 , p. 1691-1700 10 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not